Trending Topic

Thyroid gland inside human body. 3D illustration
5 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Thyroid eye disease (TED), also known as Graves’ orbitopathy, is a complex autoimmune disorder driven by an interplay of immune cells, orbital fibroblasts and tissue remodelling factors that lead to inflammation, oedema and, ultimately, potential vision loss.1 While the disease has historically been challenging to manage, recent therapeutic innovations are reshaping treatment paradigms and offering new […]

Carol Levy, DTM 2022: Benefits of insulin pump in people living with type 2 diabetes

3 mins
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Nov 24th 2022

Insulin pumps are electronic devices that help you stabilise your blood glucose levels and control your diabetes. Control-IQ technology could be a powerful management solution for therapy needs of individuals living with type 2 diabetes. In this touchENDOCRINOLOGY interview, Prof. Carol Levy (Icahn School of Medicine at Mount Sinai, New York City, NY, USA) discusses the benefits of insulin pump people in people living with type 2 diabetes and gives a brief overview of the t:slim X2 insulin pump with Control-IQ technology.

The abstract entitled: ‘Significant Reduction in Hyperglycemia and High Satisfaction with Use of Control-IQ Technology in Prior MDI and Basal-Only Insulin Users with Type 2 Diabetes was presented at the 22nd Annual Diabetes Technology Meeting, 03-05 Nov, 2022.

Questions:

  1. What are the benefits of insulin pump in people living with type 2 diabetes? (0:22)
  2. Could you give us a brief overview of the t:slim X2 insulin pump with Control-IQ technology? (1:35)

Disclosures: Carol Levy is a consultant for Dexcom and Eli Lilly and discloses grant/research support from Abbott Diabetes, Insulet and Tandem. 

Support: Interview supported by Touch Medical Media. Interview conducted by Shanice Allen.

Recorded as a highlight of DTM 2022

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup